|1.||Schmitt, Manfred: 3 articles (01/2003 - 09/2002)|
|2.||Magdolen, Viktor: 3 articles (01/2003 - 09/2002)|
|3.||Kessler, Horst: 3 articles (01/2003 - 09/2002)|
|4.||Wang, Conan K: 2 articles (09/2014 - 01/2014)|
|5.||Craik, David J: 2 articles (09/2014 - 01/2014)|
|6.||Gilon, Chaim: 2 articles (01/2012 - 01/2005)|
|7.||Bondu-Hawkins, Virginie: 2 articles (09/2009 - 06/2008)|
|8.||Hall, Pamela R: 2 articles (09/2009 - 06/2008)|
|9.||Larson, Richard S: 2 articles (09/2009 - 06/2008)|
|10.||Ye, Chunyan: 2 articles (09/2009 - 06/2008)|
11/01/2002 - "This paper reported an ongoing study of cyclic peptides as carriers of potential anti-tumor agents. "
08/02/2001 - "This study demonstrates a possibility of mimicking the well-documented antibody effects and its applications in tumor therapy by much smaller antibody-based cyclic peptides with potentially significant therapeutic advantages. "
08/01/2012 - "Although cyclization does not necessarily improve the cancer-targeting properties of linear analogues, cyclic peptides may obtain properties that allow them to be used for additional applications. "
01/01/2012 - "There are many cyclic peptides with diverse biological activities, such as antibacterial activity, immunosuppressive activity, and anti-tumor activity, and so on. "
07/31/2009 - "Using biophysical methods and fluorescence microscopy, we show that pHLIP can successfully deliver polar and membrane-impermeable cyclic peptides linked to its C terminus through the membranes of lipid vesicles and cancer cells. "
07/21/2005 - "More importantly, one of the cyclic peptides showed a protective effect against inflammation and articular destruction in DBA/1 mouse collagen-induced arthritis, a model of RA. "
10/10/1997 - "Recently peptides containing a consensus LDV sequence based on the connecting segment-1 (CS-1) of fibronectin and cyclic peptides containing an RCD motif have shown promise in modulating leukocyte migration and inflammation presumably by blocking the interaction of alpha 4 beta 1 with VCAM-1. "
|3.||Melanoma (Melanoma, Malignant)
07/01/2001 - "In the present study we investigated whether AVPs carrying cyclic peptides with an RGD integrin binding motif (RGD-AVPs) are suitable for the specific and efficient transduction of human melanoma cells. "
04/01/2010 - "Biodistribution and imaging studies in the B16 mouse melanoma modeled showed rapid tumor uptake of the radiolabeled peptides, with the cyclic peptides demonstrating prolonged tumor retention. "
01/17/2014 - "Molecular grafting onto a stable framework yields novel cyclic peptides for the treatment of multiple sclerosis."
03/10/2005 - "The mutant cyclic peptides, the cyclo(91-99)[Ala(96)]MBP(87)(-)(99) and the cyclo(87-99)[Arg(91)Ala(96)]MBP(87)(-)(99), reported previously for suppressing, to a varying degree, autoimmune encephalomyelitis in a rat animal model, were found in this study to possess the following immunomodulatory properties: (i) they suppressed the proliferation of a CD4 T-cell line raised from a multiple sclerosis patient, (ii) they scored the best in vitro TH2/TH1 cytokine ratio in peripheral blood mononuclear cell cultures derived from 13 multiple sclerosis patients, inducing IL-10 selectively, and (iii) they bound to HLA-DR4, first to be reported for cyclic MBP peptides. "
|4.||Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)
|10.||Interleukin-10 (Interleukin 10)
|1.||Drug Therapy (Chemotherapy)
|3.||Traditional Medicine (Folk Remedies)